Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Prevalence of Rheumatoid Arthritis in Chile: A Nationwide Study Performed as Part of the National Health Survey.
Durán J, Massardo L, Llanos C, Iacobelli S, Burgos PI, Cisternas M, Iruretagoyena M, Armstrong M, Aguilera R, Radrigán F, Martinez ME, Passi-Solar A, Riedemann P, Crisóstomo N, Cifuentes C, Hagedorn L, Cisternas A, Vasquez N, Margozzini P; the ENS2017 Study Group. Durán J, et al. J Rheumatol. 2020 Jul 1;47(7):951-958. doi: 10.3899/jrheum.190396. Epub 2019 Sep 1. J Rheumatol. 2020. PMID: 31474598
Educational website incorporating rheumatoid arthritis patient needs for Latin American and Caribbean countries.
Massone F, Martínez ME, Pascual-Ramos V, Quintana R, Stange L, Caballero-Uribe CV, Ferreyra-Garrot L, Kourilovitch M, Duarte M, Baumert C, Vergara C, Gareca N, Rodríguez C, Khoury V, Medina M, Cardiel MH, Massardo L. Massone F, et al. Among authors: baumert c. Clin Rheumatol. 2017 Dec;36(12):2789-2797. doi: 10.1007/s10067-017-3866-4. Epub 2017 Nov 2. Clin Rheumatol. 2017. PMID: 29098475
Topical Medications for Seborrheic Dermatitis.
Baumert C, Melo M, Vincent EC. Baumert C, et al. Am Fam Physician. 2017 Mar 1;95(5):329. Am Fam Physician. 2017. PMID: 28290646 Free article. No abstract available.
Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties.
Baumert C, Günthel M, Krawczyk S, Hemmer M, Wersig T, Langner A, Molnár J, Lage H, Hilgeroth A. Baumert C, et al. Bioorg Med Chem. 2013 Jan 1;21(1):166-77. doi: 10.1016/j.bmc.2012.10.041. Epub 2012 Nov 3. Bioorg Med Chem. 2013. PMID: 23199479
Novel structurally varied N-alkyl 1,4-dihydropyridines as ABCB1 inhibitors: structure-activity relationships, biological activity and first bioanalytical evaluation.
Hilgeroth A, Baumert C, Coburger C, Seifert M, Krawczyk S, Hempel C, Neubauer F, Krug M, Molnár J, Lage H. Hilgeroth A, et al. Among authors: baumert c. Med Chem. 2013 Jun 1;9(4):487-93. doi: 10.2174/1573406411309040002. Med Chem. 2013. PMID: 23167942
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
Coburger C, Wollmann J, Krug M, Baumert C, Seifert M, Molnár J, Lage H, Hilgeroth A. Coburger C, et al. Among authors: baumert c. Bioorg Med Chem. 2010 Jul 15;18(14):4983-90. doi: 10.1016/j.bmc.2010.06.004. Epub 2010 Jun 9. Bioorg Med Chem. 2010. PMID: 20598550
First biological evaluation of developed 3-benzyloxyfluorenes as novel class of MDR modulators.
Krug M, Voigt B, Baumert C, Lüpken R, Molnár J, Hilgeroth A. Krug M, et al. Among authors: baumert c. Eur J Med Chem. 2010 Jun;45(6):2683-8. doi: 10.1016/j.ejmech.2010.02.024. Epub 2010 Feb 13. Eur J Med Chem. 2010. PMID: 20207048
Recent advances in the development of P-gp inhibitors.
Baumert C, Hilgeroth A. Baumert C, et al. Anticancer Agents Med Chem. 2009 May;9(4):415-36. doi: 10.2174/1871520610909040415. Anticancer Agents Med Chem. 2009. PMID: 19442042 Review.
Novel insight in structure-activity relationship and bioanalysis of P-glycoprotein targeting highly potent tetrakishydroxymethyl substituted 3,9-diazatetraasteranes.
Coburger C, Wollmann J, Baumert C, Krug M, Molnár J, Lage H, Hilgeroth A. Coburger C, et al. Among authors: baumert c. J Med Chem. 2008 Sep 25;51(18):5871-4. doi: 10.1021/jm800480y. Epub 2008 Aug 21. J Med Chem. 2008. PMID: 18714979
11 results
Jump to page